Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Big pharma's dirty marketing tricks not just in us

About the author: 

The UK's drugs regulations industry is finally facing a long-overdue overhaul

The UK's drugs regulations industry is finally facing a long-overdue overhaul. It has often been entirely funded by the pharmaceutical industry, and its committees are known to be made up of or include individuals who have close - or very close - contacts with drug companies.

So, it has finally occurred to the UK government that this may not be an ideal state of affairs. But then, they've also had to apologise and make amends too many times when the regulator has overlooked some problem or other - such as a drug that kills people.

The most recent calamity concerns the antidepressant Seroxat and the way in which the drugs regulator overlooked vital evidence of its dangers. The BBC television programme Panorama discovered that the drug could cause self-harm, aggression and even suicide, a claim that the regulator has constantly denied. However, the programme's reporters say that the regulator has been sitting on the incriminating data for 13 years and, yet, has never issued a warning to the public.

WDDTY first alerted its readers to the dangers of Seroxat seven years ago. We pointed out at the time that the drugs regulator had received documentation of 54 serious adverse reactions associated with the drug.

Now, the government has decided to do something about it. Government officials have drawn up a code of conduct for the Medicines and Healthcare Products Regulatory Authority, which licenses the Commission for the Safety of Medicines. The new code recommends that Authority members should not hold any interests in the pharmaceutical industry, and that the group should include two lay members.

In a remarkable understatement, Dr Ian Gibson, chairman of the House of Commons Science and Technology Select Committee, said that the MHPRA was suffering from an image problem.


Drugs for arthritis

Reflexology fixed bowel function and cured a cyst

You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved